| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
21,018 |
15,991 |
$1.04M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,642 |
7,158 |
$324K |
| H2010 |
Comprehensive medication services, per 15 minutes |
1,194 |
886 |
$240K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
823 |
727 |
$53K |
| 99401 |
|
2,772 |
2,106 |
$45K |
| 99402 |
|
1,215 |
935 |
$41K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,788 |
2,158 |
$39K |
| 3008F |
|
24,235 |
18,256 |
$28K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
339 |
298 |
$23K |
| 3074F |
|
18,236 |
14,094 |
$22K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
288 |
254 |
$17K |
| 3078F |
|
11,261 |
8,893 |
$17K |
| 93000 |
|
1,387 |
1,196 |
$17K |
| 3079F |
|
9,240 |
7,362 |
$15K |
| 96160 |
|
3,239 |
2,724 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,278 |
523 |
$9K |
| 96127 |
|
2,473 |
2,103 |
$7K |
| 80305 |
|
2,273 |
1,599 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
284 |
238 |
$7K |
| 90674 |
|
329 |
271 |
$6K |
| 81025 |
|
1,048 |
826 |
$5K |
| 99490 |
Ccm add 20min |
239 |
225 |
$5K |
| 3080F |
|
1,770 |
1,395 |
$5K |
| 81002 |
|
2,575 |
2,095 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
356 |
294 |
$3K |
| 3075F |
|
2,005 |
1,629 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
320 |
264 |
$3K |
| 3077F |
|
1,142 |
893 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
28 |
25 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
142 |
114 |
$1K |
| 90686 |
|
47 |
44 |
$977.93 |
| 82947 |
|
505 |
381 |
$943.57 |
| 82950 |
|
357 |
295 |
$761.14 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
742 |
634 |
$721.93 |
| 94760 |
|
805 |
631 |
$482.68 |
| 71046 |
Radiologic examination, chest; 2 views |
16 |
12 |
$163.71 |
| 99406 |
|
34 |
30 |
$131.23 |
| 99407 |
|
36 |
31 |
$116.94 |
| 82948 |
|
51 |
27 |
$107.49 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
20 |
18 |
$29.30 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
30 |
26 |
$11.26 |
| 99454 |
|
12 |
12 |
$2.54 |
| 99457 |
|
13 |
12 |
$2.38 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
13 |
12 |
$1.26 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
14 |
13 |
$0.00 |
| 1101F |
|
12 |
12 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
43 |
41 |
$0.00 |
| 3017F |
|
15 |
13 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
13 |
12 |
$0.00 |
| 1036F |
|
13 |
12 |
$0.00 |
| 1159F |
|
13 |
13 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
27 |
26 |
$0.00 |
| G8404 |
Lower extremity neurological exam performed and documented |
45 |
40 |
$0.00 |
| 1494F |
|
12 |
12 |
$0.00 |